LEXEO THERAPEUTICS - Q3 2026 NET LOSS $38.30 MLN OR $0.43 PER SHARE VS $20.30 MLN OR $0.33 IN Q3 2025
LEXEO THERAPEUTICS - Q3 2026 NET LOSS $38.30 MLN OR $0.43 PER SHARE VS $20.30 MLN OR $0.33 IN Q3 202
LEXEO THERAPEUTICS - Q3 2026 NET LOSS $38.30 MLN OR $0.43 PER SHARE VS $20.30 MLN OR $0.33 IN Q3 202